Verastem Market Cap 2011-2018 | VSTM

Verastem market cap history and chart from 2011 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Verastem market cap as of December 12, 2018 is $0.32B.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.324B $0.000B
Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib (VS-6063), an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. The company's defactinib is in Phase 1b study for the treatment of pancreatic cancer, as well as in Phase 1/2 clinical trial for the treatment of ovarian cancer, non-small cell lung cancer, mesothelioma, and pancreatic cancer. It also engages in developing duvelisib, an investigational oral therapy that targets the PI3K signaling pathway, as well as attacks malignant B-cells and T-cells and disrupt the tumor microenvironment to help thwart their growth and proliferation for patients with lymphatic cancers through the dual inhibition of PI3K delta and gamma.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $125.156B 14.15
Gilead Sciences (GILD) United States $88.147B 10.61
Biogen (BIIB) United States $65.000B 13.16
Celgene (CELG) United States $49.577B 9.62
Illumina (ILMN) United States $49.527B 57.69
Vertex Pharmaceuticals (VRTX) United States $44.838B 78.33
Regeneron Pharmaceuticals (REGN) United States $40.899B 20.72
Alexion Pharmaceuticals (ALXN) United States $26.105B 17.86
BioMarin Pharmaceutical (BMRN) United States $16.829B 0.00
Incyte (INCY) United States $14.401B 398.06
Seattle Genetics (SGEN) United States $9.921B 0.00
Exact Sciences (EXAS) United States $8.823B 0.00
BeiGene (BGNE) Cayman Islands $8.430B 0.00
Sarepta Therapeutics (SRPT) United States $8.362B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.032B 0.00
QIAGEN (QGEN) Netherlands $8.002B 25.59
Bio-Rad Laboratories (BIO.B) United States $7.571B 48.41
Exelixis (EXEL) United States $6.518B 18.48
Bio-Techne Corp (TECH) United States $6.117B 41.32
Bluebird Bio (BLUE) United States $5.892B 0.00
Alkermes (ALKS) Ireland $5.516B 3550.00
Galapagos (GLPG) Belgium $5.475B 0.00
Amarin (AMRN) Ireland $5.419B 0.00
Immunomedics (IMMU) United States $3.708B 0.00
Guardant Health (GH) United States $3.639B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.601B 0.00
Array BioPharma (ARRY) United States $3.439B 0.00
Horizon Pharma Public (HZNP) Ireland $3.314B 13.63
Emergent Biosolutions (EBS) United States $3.290B 27.72
ARGENX SE-ADR (ARGX) Netherlands $3.285B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.283B 0.00
Allogene Therapeutics (ALLO) United States $3.184B 0.00
Ligand Pharmaceuticals (LGND) United States $3.144B 24.05
Akcea Therapeutics (AKCA) United States $2.880B 0.00
Repligen (RGEN) United States $2.660B 83.08
Ascendis Pharma (ASND) Denmark $2.631B 0.00
Genomic Health (GHDX) United States $2.628B 88.71
Allakos (ALLK) United States $2.601B 0.00
China Biologic Products (CBPO) China $2.571B 18.30
Blueprint Medicines (BPMC) United States $2.541B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.384B 0.00
Myriad Genetics (MYGN) United States $2.340B 23.18
ACADIA Pharmaceuticals (ACAD) United States $2.311B 0.00
Halozyme Therapeutics (HALO) United States $2.270B 50.65
Global Blood Therapeutics (GBT) United States $2.258B 0.00
MyoKardia (MYOK) United States $2.250B 0.00
Acceleron Pharma (XLRN) United States $2.209B 0.00
Arena Pharmaceuticals (ARNA) United States $2.108B 0.00
Amicus Therapeutics (FOLD) United States $2.077B 0.00
Denali Therapeutics (DNLI) United States $1.970B 0.00
Atara Biotherapeutics (ATRA) United States $1.938B 0.00
AnaptysBio (ANAB) United States $1.910B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.888B 0.00
Reata Pharmaceuticals (RETA) United States $1.801B 0.00
REGENXBIO (RGNX) United States $1.792B 24.04
Innoviva (INVA) United States $1.776B 10.05
Medicines (MDCO) United States $1.707B 0.00
Rubius Therapeutics (RUBY) United States $1.566B 0.00
Spark Therapeutics (ONCE) United States $1.560B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.519B 0.00
WAVE Life Sciences (WVE) Singapore $1.476B 0.00
Cambrex (CBM) United States $1.467B 10.95
Editas Medicine (EDIT) United States $1.449B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.394B 110.75
Aimmune Therapeutics (AIMT) United States $1.375B 0.00
Mirati Therapeutics (MRTX) United States $1.360B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.360B 0.00
Myovant Sciences (MYOV) United Kingdom $1.292B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.283B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.269B 0.00
G1 THERAPEUTICS (GTHX) United States $1.268B 0.00
Sangamo Therapeutics (SGMO) United States $1.252B 0.00
NeoGenomics (NEO) United States $1.239B 102.00
Zai Lab Unsponsored ADR (ZLAB) China $1.231B 0.00
Insmed (INSM) United States $1.220B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.210B 0.00
Lion Biotechnologies (IOVA) United States $1.203B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.180B 0.00
UniQure (QURE) Netherlands $1.102B 0.00
Clovis Oncology (CLVS) United States $1.096B 0.00
Fate Therapeutics (FATE) United States $1.084B 0.00
Retrophin (RTRX) United States $1.045B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.014B 0.00
Audentes Therapeutics (BOLD) United States $1.011B 0.00
Apellis Pharmaceuticals (APLS) United States $1.008B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.969B 0.00
Novavax (NVAX) United States $0.949B 0.00
Puma Biotechnology (PBYI) United States $0.921B 0.00
Athenex (ATNX) United States $0.899B 0.00
DBV Technologies (DBVT) France $0.887B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.842B 0.00
Intra-Cellular Therapies (ITCI) United States $0.838B 0.00
Cellectis (CLLS) France $0.838B 0.00
Solid Biosciences (SLDB) United States $0.828B 0.00
Revance Therapeutics (RVNC) United States $0.811B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.786B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.784B 0.00
Acorda Therapeutics (ACOR) United States $0.779B 9.86
Vericel (VCEL) United States $0.771B 0.00
Heska (HSKA) United States $0.761B 62.29
Y-mAbs Therapeutics (YMAB) United States $0.751B 0.00
Aptinyx (APTX) United States $0.737B 0.00
AC Immune SA (ACIU) Switzerland $0.731B 0.00
Dynavax Technologies (DVAX) United States $0.730B 0.00
Scholar Rock Holding (SRRK) United States $0.726B 0.00
Intellia Therapeutics (NTLA) United States $0.722B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.716B 0.00
Gritstone Oncology (GRTS) United States $0.716B 0.00
Principia Biopharma (PRNB) United States $0.702B 0.00
Viking Therapeutics (VKTX) United States $0.701B 0.00
InflaRx (IFRX) Germany $0.691B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.690B 0.00
Coherus BioSciences (CHRS) United States $0.682B 0.00
CytomX Therapeutics (CTMX) United States $0.676B 0.00
UNITY Biotechnology (UBX) $0.666B 0.00
ANI Pharmaceuticals (ANIP) United States $0.646B 12.35
UROGEN PHARMA (URGN) Israel $0.640B 0.00
Cara Therapeutics (CARA) United States $0.611B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.596B 0.00
TWIST BIOSCIENC (TWST) United States $0.584B 0.00
AVROBIO (AVRO) United States $0.584B 0.00
Eidos Therapeutics (EIDX) United States $0.562B 0.00
ObsEva SA (OBSV) Switzerland $0.560B 0.00
Kezar Life Sciences (KZR) United States $0.560B 0.00
RA PHARMCTL INC (RARX) United States $0.553B 0.00
Kura Oncology (KURA) United States $0.550B 0.00
Arcus Biosciences (RCUS) United States $0.545B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.535B 0.00
Arvinas (ARVN) United States $0.511B 0.00
Inovio Pharmaceuticals (INO) United States $0.506B 0.00
Epizyme (EPZM) United States $0.500B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.496B 0.00
Zymeworks (ZYME) Canada $0.480B 0.00
Prothena (PRTA) Ireland $0.475B 0.00
BeyondSpring (BYSI) United States $0.462B 0.00
Replimune (REPL) United States $0.460B 0.00
Osiris Therapeutics (OSIR) United States $0.458B 0.00
Anika Therapeutics (ANIK) United States $0.446B 18.46
Achillion Pharmaceuticals (ACHN) United States $0.442B 0.00
PDL BioPharma (PDLI) United States $0.441B 7.19
Cytokineticsorporated (CYTK) United States $0.438B 0.00
Senesco Technologies (ELOX) United States $0.434B 0.00
Five Prime Therapeutics (FPRX) United States $0.427B 0.00
Kindred Biosciences (KIN) United States $0.426B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.424B 0.00
Zealand Pharma (ZEAL) Denmark $0.405B 4.47
Sinovac Biotech (SVA) China $0.403B 0.00
Mesoblast (MESO) Australia $0.399B 0.00
Abeona Therapeutics (ABEO) United States $0.397B 0.00
MediciNova (MNOV) United States $0.394B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.375B 0.00
Cellular Biomedicine (CBMG) United States $0.370B 0.00
ResTORbio (TORC) United States $0.369B 0.00
MeiraGTx Holdings (MGTX) United States $0.355B 0.00
Stemline Therapeutics (STML) United States $0.345B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.344B 0.00
Krystal Biotech (KRYS) United States $0.343B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.339B 0.00
Sorrento Therapeutics (SRNE) United States $0.333B 54.40
Liquidia Technologies (LQDA) United States $0.332B 0.00
Agenus (AGEN) United States $0.319B 0.00
Evelo Biosciences (EVLO) United States $0.316B 0.00
Albireo Pharma (ALBO) United States $0.305B 0.00
Kodiak Sciences (KOD) United States $0.303B 0.00
Seres Therapeutics (MCRB) United States $0.295B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.294B 0.00
Syros Pharmaceuticals (SYRS) United States $0.291B 0.00
Athersys (ATHX) United States $0.286B 0.00
MannKind (MNKD) United States $0.284B 0.00
Merus (MRUS) Netherlands $0.281B 0.00
LogicBio Therapeutics (LOGC) United States $0.273B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.271B 0.00
Geron (GERN) United States $0.270B 0.00
Magenta Therapeutics (MGTA) United States $0.263B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.258B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.257B 0.00
Intec Pharma (NTEC) Israel $0.256B 0.00
Arbutus Biopharma (ABUS) Canada $0.255B 0.00
BioDelivery Sciences (BDSI) United States $0.252B 0.00
Kadmon Holdings (KDMN) United States $0.240B 0.00
Adverum Biotechnologies (ADVM) United States $0.240B 0.00
Celcuity (CELC) United States $0.233B 0.00
Equillium (EQ) United States $0.231B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
Aduro Biotech (ADRO) United States $0.226B 0.00
TOCAGEN INC (TOCA) United States $0.224B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.223B 0.00
PSivida (EYPT) United States $0.221B 0.00
ADMA Biologics Inc (ADMA) United States $0.220B 0.00
Strongbridge Biopharma (SBBP) United States $0.213B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.211B 0.00
Celyad SA (CYAD) Belgium $0.209B 0.00
Synlogic (SYBX) United States $0.194B 0.00
Kala Pharmaceuticals (KALA) United States $0.193B 0.00
Kamada (KMDA) Israel $0.193B 17.78
Urovant Sciences (UROV) United States $0.188B 0.00
Proteostasis Therapeutics (PTI) United States $0.187B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.185B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.182B 0.00
Idera Pharmaceuticals (IDRA) United States $0.182B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
Allena Pharmaceuticals (ALNA) United States $0.174B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.174B 0.00
ChromaDex (CDXC) United States $0.169B 0.00
Protagonist Therapeutics (PTGX) United States $0.169B 0.00
BioTime (BTX) United States $0.165B 0.00
Compugen (CGEN) Israel $0.164B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.164B 0.00
Unum Therapeutics (UMRX) United States $0.159B 0.00
CorMedix Inc (CRMD) United States $0.158B 0.00
Cohbar (CWBR) United States $0.157B 0.00
XBiotech (XBIT) United States $0.157B 0.00
Palatin Technologies (PTN) United States $0.156B 19.17
ASLAN Pharmaceuticals (ASLN) Singapore $0.153B 0.00
Constellation Pharmaceuticals (CNST) United States $0.151B 0.00
Axovant Sciences (AXON) United Kingdom $0.148B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.144B 0.00
Enzo Biochem (ENZ) United States $0.141B 0.00
Cerecor (CERC) United States $0.138B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.133B 0.00
Menlo Therapeutics (MNLO) United States $0.129B 0.00
Pfenex (PFNX) United States $0.127B 0.00
XOMA (XOMA) United States $0.124B 0.00
Selecta Biosciences (SELB) United States $0.123B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.121B 0.00
Organovo Holdings (ONVO) United States $0.121B 0.00
Catalyst Biosciences (CBIO) United States $0.120B 0.00
Mersana Therapeutics (MRSN) United States $0.120B 0.00
Applied Genetic Technologies (AGTC) United States $0.119B 0.00
Eleven Biotherapeutics (SESN) United States $0.119B 0.00
Spero Therapeutics (SPRO) United States $0.115B 0.00
NantKwest (NK) United States $0.115B 0.00
VBI Vaccines (VBIV) United States $0.107B 0.00
Cocrystal Pharma (COCP) United States $0.106B 118.00
Pluristem Therapeutics (PSTI) Israel $0.105B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.104B 0.00
Cue Biopharma (CUE) United States $0.102B 0.00
ETON PHARMACEUT (ETON) United States $0.102B 0.00
Neothetics (EVFM) United States $0.100B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Anavex Life Sciences (AVXL) United States $0.096B 0.00
Axsome Therapeutics (AXSM) United States $0.096B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.096B 0.00
Motif Bio Plc (MTFB) United States $0.093B 0.00
Chiasma (CHMA) United States $0.093B 0.00
Signal Genetics (MGEN) United States $0.092B 0.00
Cel-Sci (CVM) United States $0.091B 0.00
Aptose Biosciences (APTO) Canada $0.091B 0.00
Provention Bio (PRVB) United States $0.090B 0.00
ScPharmaceuticals (SCPH) United States $0.089B 0.00
Mustang Bio (MBIO) United States $0.088B 0.00
Cidara Therapeutics (CDTX) United States $0.083B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.081B 0.00
OVID THERAPEUTC (OVID) United States $0.076B 0.00
VolitionRX (VNRX) Singapore $0.075B 0.00
ITUS (ANIX) United States $0.074B 0.00
VTv Therapeutics (VTVT) United States $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.073B 0.00
Checkpoint Therapeutics (CKPT) United States $0.072B 0.00
BioXcel Therapeutics (BTAI) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.069B 0.00
Monster Digital (INNT) United States $0.069B 0.00
NewLink Genetics (NLNK) United States $0.067B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.066B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Bellerophon Therapeutics (BLPH) United States $0.065B 0.00
Sophiris Bio (SPHS) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.063B 0.00
Fortress Biotech (FBIO) United States $0.062B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Ophthotech (OPHT) United States $0.060B 0.00
Alcobra (ARCT) United States $0.058B 0.00
Evogene (EVGN) Israel $0.058B 0.00
Arsanis (ASNS) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
AEterna Zentaris (AEZS) United States $0.054B 10.31
Versartis (ARAV) United States $0.053B 4.69
VistaGen Therapeutics (VTGN) United States $0.053B 0.00
Vaccinex (VCNX) United States $0.053B 0.00
Entera Bio (ENTX) Israel $0.053B 0.00
Trevena (TRVN) United States $0.051B 0.00
Aptevo Therapeutics (APVO) United States $0.049B 0.00
OncoSec Medical (ONCS) United States $0.049B 0.00
Asterias Biotherapeutics (AST) United States $0.048B 0.00
Celldex Therapeutics (CLDX) United States $0.047B 0.00
Caladrius Biosciences (CLBS) United States $0.047B 0.00
Leap Therapeutics (LPTX) United States $0.046B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.043B 0.00
Zosano Pharma (ZSAN) United States $0.043B 0.00
Clearside Biomedical (CLSD) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.039B 0.00
Oncolytics Biotech (ONCY) Canada $0.039B 0.00
Oncobiologics (OTLK) United States $0.038B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Galena Biopharma (SLS) United States $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
Proteon Therapeutics (PRTO) United States $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 5.44
Histogenics (HSGX) United States $0.033B 0.00
TRACON Pharmaceuticals (TCON) United States $0.033B 0.00
AquaBounty Technologies (AQB) United States $0.033B 0.00
VIVUS (VVUS) United States $0.030B 0.00
AZURRX BIOPHARM (AZRX) United States $0.030B 0.00
GTx (GTXI) United States $0.030B 0.00
Oragenics (OGEN) United States $0.029B 0.00
DiaMedica Therapeutics (DMAC) United States $0.028B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
Vical (VICL) United States $0.026B 0.00
BioPharmX (BPMX) United States $0.026B 0.00
Curis (CRIS) United States $0.025B 0.00
Aileron Therapeutics (ALRN) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.022B 0.00
Benitec Biopharma (BNTC) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
CytRx (CYTR) United States $0.018B 0.00
GENPREX INC (GNPX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Cellect Biotechnology (APOP) Israel $0.017B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 8.40
Soligenix (SNGX) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.015B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.015B 0.00
Edge Therapeutics (EDGE) United States $0.014B 0.00
Gemphire Therapeutics (GEMP) United States $0.014B 0.00
Adial Pharmaceuticals (ADIL) United States $0.013B 0.00
Prana Biotechnology (PRAN) Australia $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Vital Therapies (VTL) United States $0.012B 0.00
RestorGenex (DFFN) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Cerulean Pharma (DARE) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
AmpliPhi Biosciences (APHB) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00